Qual é o preço para Hyloris Pharmaceuticals S.A. (HYL)

O preço para Hyloris Pharmaceuticals S.A. (HYL) é $5.22

Qual é a capitalização de mercado para Hyloris Pharmaceuticals S.A. (HYL)

A capitalização de mercado para Hyloris Pharmaceuticals S.A. (HYL) é $146.14M

Histórico de Preços de Hyloris Pharmaceuticals S.A. (HYL)

Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and bringing to market pharmaceutical products designed to fulfill critical unmet medical needs. The company's focus areas include cardiovascular health, oncology, women's health, and other significant therapeutic domains. Its cardiovascular portfolio features treatments for conditions such as atrial fibrillation, acute coronary syndrome, advanced and congestive heart failure, and coronary heart disease. Beyond this, Hyloris addresses a diverse range of other ailments, including post-operative pain management, dental indications, severe and recurring vulvovaginal candidiasis, specific cancers (like acute myeloid leukemia and small cell lung cancer), interstitial cystitis/painful bladder syndrome (IC/PBS), attention deficit hyperactivity disorder (ADHD), and various viral infections. Established in 2012, Hyloris Pharmaceuticals SA is headquartered in Liège, Belgium.

Ano	Desempenho
2026 (TTM)	-2.96%
2025	17.57%
2024	-54.17%
2023	-2.50%
2022	-29.03%
2021	58.84%
2020	0.00%

Ano

Desempenho

2026 (TTM)

-2.96%

2025

17.57%

2024

-54.17%

2023

-2.50%

2022

-29.03%

2021

58.84%

2020

0.00%

Empresa	Preço da ação	Variação 1a%	País
Vertex Pharmaceuticals Incorporated VRTX.US	$553.09	42.20%	US
Argenx SE ARGX.US	$1.02K	50.56%	NL
Moderna, Inc. MRNA.US	$158.64	525.80%	US
CSL Limited CSL.AX	$122.47	-12.71%	AU
Lonza Group AG LONN.SW	$772.27	8.67%	CH

Empresa

Preço da ação

Variação 1a%

País